Company Filing History:
Years Active: 2022
Title: Alessandro Papale: Innovator in Neuroprotective Peptides
Introduction
Alessandro Papale is a notable inventor based in Milan, Italy. He has made significant contributions to the field of neuroprotective agents through his innovative research and patents. His work focuses on enhancing cognitive functions and providing therapeutic solutions for neurodegenerative disorders.
Latest Patents
Alessandro Papale holds a patent for a neuroprotective peptide that acts as an inhibitor of MAPK3 (ERK1 MAP kinase). This patent, which includes 1 patent, discloses polypeptides capable of stimulating the global ERK signaling pathway in the brain. The invention also covers related polynucleotides, vectors, host cells, and pharmaceutical compositions that inhibit MAPK3, thereby stimulating the global ERK signaling pathway. Furthermore, the patent outlines the use of these inhibitors or stimulators in treating neurodegenerative or neuropsychiatric disorders and cognitive impairments.
Career Highlights
Alessandro Papale is affiliated with University College Cardiff Consultants Limited, where he continues to advance his research in neuroprotection and cognitive enhancement. His work has garnered attention for its potential applications in medicine and therapeutic interventions.
Collaborations
Alessandro collaborates with esteemed colleagues, including Riccardo Brambilla and Stefania Fasano, who contribute to his research endeavors and help expand the impact of his innovations.
Conclusion
Alessandro Papale's contributions to the field of neuroprotective peptides highlight his role as an influential inventor. His patented work offers promising avenues for treating cognitive impairments and neurodegenerative disorders.